AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board

By Jaclyn Diaz

Published March 23, 2021 at 12:34 AM MDT

Facebook
Twitter
LinkedIn
Email

In an unusual post-midnight statement, the National Institute of Allergy and Infectious Diseases said AstraZeneca might have used old data for its COVID-19 vaccine trial.

NPR Coronavirus Updates

Facebook
Twitter
LinkedIn
Email

Jaclyn Diaz

See stories by Jaclyn Diaz